You searched for "data"

868 results found

Help to handle increased volumes of urethral catheterisations safely

With urethral catheterisation volumes currently considerably increased, we are pleased to be able to announce that NHS Supply Chain is now listing the...

An update on lower pole stone management for 2015

Introduction Urolithiasis is an increasing healthcare problem, with an estimated lifetime prevalence of up to 15% [1]. The number of interventions undertaken for stone disease has increased dramatically over recent years, particularly with respect to ureteroscopy and percutaneous nephrolithotomy (PCNL)...

RSM (Royal Society of Medicine) Inspiration Care in Urology

Following the success of the 2024 event, this second edition will spotlight innovative treatment pathways and models of care being implemented across the UK. Expect practical insights and inspiring stories from leaders in urological service delivery.

Action Bladder Cancer UK: Understanding Bladder Cancer and the latest developments. A Nurses Education Day

This Education Day aims to provide nurses with up-to-date knowledge on bladder cancer treatments and the newest developments. Urology nurses and cancer nurses across the UK will have the opportunity to network and share their experiences and expertise. This event is also open to nurses who wish to extend their knowledge of bladder cancer and who may be working in other areas of urology or cancer care.

RSM (Royal Society of Medicine) Tackling the Rise of Infections and Resistance in Urology

Save the date for this comprehensive all-day meeting addressing the growing challenge of infections in urology, antibiotic resistance, and antimicrobial stewardship. Sessions will cover diagnosis, epidemiology, emergency management, and prevention strategies. The programme will also explore the role of non-antibiotic...

Intravesical GAG replacement therapies for bladder pain syndrome / interstitial cystitis – an update

The barrier function of the glycosaminoglycan (GAG) layer of the urothelium was identified by Parsons in 1975, and intravesical therapies to treat chronic inflammatory conditions of the bladder were developed soon after. However, the active role of the urothelium in...

Metabolic screening and stone-prevention in urolithiasis patients

The incidence and prevalence of kidney stones is increasing [1,2]. Significant recurrence rates are noted with 14% of patients experiencing a further episode at one year, 35% at five years, and 52% at 10 years [3]. Over 10% of stone...

Imperial Prostate & Focal Therapy Society Masterclass

   

BAUN Annual Conference 2024